Jeffrey Zekaukas
Stock Analyst at JP Morgan
(1.26)
# 3,678
Out of 5,032 analysts
26
Total ratings
26.67%
Success rate
-4.3%
Average return
Main Sectors:
Stocks Rated by Jeffrey Zekaukas
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MOS The Mosaic Company | Maintains: Overweight | $35 → $37 | $29.32 | +26.19% | 6 | Aug 11, 2025 | |
| EMN Eastman Chemical Company | Downgrades: Neutral | $112 → $76 | $61.28 | +24.02% | 8 | Apr 28, 2025 | |
| ECL Ecolab | Downgrades: Neutral | $200 → $220 | $276.75 | -20.51% | 5 | Feb 14, 2024 | |
| LYB LyondellBasell Industries | Upgrades: Overweight | $95 → $100 | $46.19 | +116.50% | 3 | Feb 5, 2024 | |
| AVY Avery Dennison | Maintains: Overweight | $185 → $218 | $159.44 | +36.73% | 2 | Feb 1, 2024 | |
| LLY Eli Lilly and Company | Maintains: Equal-Weight | $148 → $157 | $802.83 | -80.44% | 2 | Aug 14, 2020 |
The Mosaic Company
Aug 11, 2025
Maintains: Overweight
Price Target: $35 → $37
Current: $29.32
Upside: +26.19%
Eastman Chemical Company
Apr 28, 2025
Downgrades: Neutral
Price Target: $112 → $76
Current: $61.28
Upside: +24.02%
Ecolab
Feb 14, 2024
Downgrades: Neutral
Price Target: $200 → $220
Current: $276.75
Upside: -20.51%
LyondellBasell Industries
Feb 5, 2024
Upgrades: Overweight
Price Target: $95 → $100
Current: $46.19
Upside: +116.50%
Avery Dennison
Feb 1, 2024
Maintains: Overweight
Price Target: $185 → $218
Current: $159.44
Upside: +36.73%
Eli Lilly and Company
Aug 14, 2020
Maintains: Equal-Weight
Price Target: $148 → $157
Current: $802.83
Upside: -80.44%